European pharmaceutical bosses have called on the EU to increase drug prices towards the much higher levels paid by the US, ...

The U.S. pays the most for drugs in the world, often nearly three times that of other developed nations. "European price ...

Company has reported net profit after tax of Rs 44.53 Crore in latest quarter.The company’s top management includes Mr.Arvind Uppal, Mr.Narasimhan Eswar, Mr.Arumalla Hari Bhavanarayana Reddy, Mr.Anil ...

Trump's recent announcement that he's procured $7 trillion in incoming investments to the U.S. may very well have been an underestimate.

The pharmaceutical firm will establish a research innovation hub in California, and manufacturing facilities in Florida, ...

European drugmaker Novartis (NVS), best known for blockbuster drugs like Entresto, Cosentyx, and Kesimpta, just announced a major U.S.

“We believe we can manage the tariffs — though of course they will be very painful — so while that is a factor (behind this ...

Swiss pharmaceutical giant Novartis announced Thursday that it plans to build a $1.1 billion research hub in San Diego as ...

Novartis plans to spend $23 billion over the next five years to expand its manufacturing, research and technology presence in the U.S.

It has been a choppy week for European and global markets as investors have been reacting to the frequent developments in ...

Swiss pharmaceutical company, Novartis, has announced plans to build a new, $1.1 billion biomedical research complex in San ...

Swiss drugmaker Novartis said on Thursday it plans to spend $23 billion to build and expand 10 facilities in the U.S., as it ...